Analysts' Actions -- Medtronic, Nokia, Paccar, Verizon and More

RATINGS CHANGES

AmerisourceBergen (ABC) was upgraded to buy at TheStreet Ratings. You can view the full analysis from the report here: ABC.

DSW (DSW) was downgraded to hold at Jefferies. $25 price target. The company has limited earnings upside potential, Jefferies said. 

Dexcom (DXCM) was downgraded to equal-weight from overweight at Morgan Stanley. $66 price target. Libre risk is not yet factored into the stock, Morgan Stanley said. 

Medtronic (MDT) was downgraded to equal-weight from overweight at Morgan Stanley. $77 price target. The company is facing growth challenges, Morgan Stanley said. 

Methanex (MEOH) was downgraded to market perform from outperform at Raymond James. $48 price target. Methanol prices will likely fade soon, Raymond James said. 

Nokia (NOK) was downgraded to neutral from outperform at Oppenheimer. The company is seeing muted spending trends, Oppenheimer said. 

Paccar (PCAR) was downgraded to neutral from outperform at Baird. $62 price target. The valuation is less attractive, as the stock outperformed the broader market by 25% last year, Baird said. 

Valmont Industries (VMI) was downgraded to hold at TheStreet Ratings. You can view the full analysis from the report here: VMI.

Verizon (VZ) was upgraded to buy from neutral at Citigroup. $60 price target. The company is expanding its addressable market, Citi said. 

Xilinx (XLNX) was downgraded to reduce from neutral at Nomura. $45 price target. The valuation is less attractive, as the company is valued at 26x expected earnings, Nomura said. 

Xerox (XRX) was upgraded to outperform from neutral at Credit Suisse. $8 price target. Cost-savings should drive margin expansion, following the business spin, Credit Suisse said. 

This article was written by a staff member of TheStreet.

More from Stocks

Jim Cramer: Bank of America Expects 4% Economic Growth in Q2

Jim Cramer: Bank of America Expects 4% Economic Growth in Q2

Google, Morgan Stanley, IBM and Texas Instruments - 5 Things You Must Know

Google, Morgan Stanley, IBM and Texas Instruments - 5 Things You Must Know

Biotech's Coming Back to Life: Cramer's 'Off the Charts'

Biotech's Coming Back to Life: Cramer's 'Off the Charts'

Video: Here's How Goldman Sachs May Change Under David Solomon

Video: Here's How Goldman Sachs May Change Under David Solomon

J&J Vows to Fight Verdict Linking Baby Powder to Ovarian Cancer

J&J Vows to Fight Verdict Linking Baby Powder to Ovarian Cancer